Home › Forums › Investments in the US › Summary of CNBC “Mad Money” Episodes › Mad Money: Key points from May 10, 2024 (Friday) Episode
- This topic is empty.
-
AuthorPosts
-
-
2024-05-13 at 12:18 AM #8009
暮眞★潤 (Jun Kurema)
KeymasterThis page contains summary of CNBC program “Mad Money w/ Jim Cramer” which was on air on Friday, May 10, 2024. It also contains links to CNBC sites which contain video clips and transcripts.
(1) Cramer’s week ahead: Earnings from Home Depot, Alibaba, Walmart (https://www.cnbc.com/2024/05/10/cramers-week-ahead-earnings-from-home-depot-alibaba-walmart.html)
- CNBC’s Jim Cramer on Friday guided investors through next week’s market action.
- He’ll be following earnings from companies including Home Depot, Alibaba and Walmart, as well as listening to commentary from Cleveland Federal Reserve Bank President Loretta Mester.
(2) [No Video Clip for non-Club members] Executive Interview: CRH CEO Albert Manifold sits down with Jim Cramer (https://www.cnbc.com/video/2024/05/10/crh-ceo-albert-manifold-sits-down-with-jim-cramer.html)
CRH CEO Albert Manifold joins ‘Mad Money’ host Jim Cramer to talk Q1 results, revenue growth and more.
Ticker: CRH
(3) [No Video Clip for non-Club members] This is the kind of bull market behavior we haven’t seen in ages, says Jim Cramer (https://www.cnbc.com/video/2024/05/10/this-is-the-kind-of-bull-market-behavior-we-havent-seen-in-ages-says-jim-cramer.html)
‘Mad Money’ host Jim Cramer takes a look at the bull market trends were seeing right now.
(4) Executive Interview: Recursion Pharmaceuticals CEO explains how AI could make drug development faster and less costly (https://www.cnbc.com/2024/05/10/recursion-pharmaceuticals-ceo-says-ai-speeds-up-new-drug-development.html)
- In a Friday interview with CNBC’s Jim Cramer, Recursion Pharmaceuticals CEO Chris Gibson discussed how his company is using artificial intelligence and machine learning to create new drugs.
- Recursion Pharmaceuticals is a clinical-stage biotech company that received a $50 million investment from Nvidia last summer.
Ticker: RXRX
(5) Cramer’s Lightning Round: Bank of America is a buy (https://www.cnbc.com/2024/05/10/cramers-lightning-round-bank-of-america-is-a-buy.html)
- Biogen: “I’m not really impressed with what they’re doing.”
- Kratos: ”…Let’s keep it at the size that you have it, because that’s, that’s had a very, very nice move, and I don’t want to come in on top of it.”
- Micron: “I like Micron, and I like Sanjay Mehrotra [buy, buy, buy!].”
- Bank of America: ”[buy, buy, buy!].”
- Fidelis Insurance Holdings: “Not a favorite.”
- JFrog: ”…I would be a seller of almost all the enterprise software companies here.”
- Chevron: ”[buy, buy, buy!]”
Ticker: BIIB, KTS, MU, BAC, FIHL, FROG, CVX
(6) [No Video Clip for non-Club members] AM I Diversified: Jim Cramer grades viewer portfolios on diversification (https://www.cnbc.com/video/2024/05/10/jim-cramer-grades-viewer-portfolios-on-diversification.html)
‘Mad Money’ host Jim Cramer takes a closer look at viewer portfolio’s to grade them on diversification.
Other Stocks Discussed (calls with audience): Honeywell (HON), Morgan Stanley (MS)
Ref: Links to other sites that relate to episode of May 10, 2024
- Podcast at Spotify (Sound from Spotify)
- Internet Archive(Video & Texts per minute)
****************************
Previous episode Next Episode
-
-
AuthorPosts
- The topic ‘Mad Money: Key points from May 10, 2024 (Friday) Episode’ is closed to new replies.